Medication info

Celsita Tablet 25mg (Sitagliptin Hydrochloride Hydrate)

Prescription medicationTabletOralExpired
Ingredient · strength
Sitagliptin Hydrochloride Hydrate›28.35mg / 1 tablet
Manufacturer / importer
Celltrion Pharmaceutical Co., Ltd.
Appearance
Light orange, round, double convex, film-coated tablet
Packaging
28 tablets (14 tablets/PTP x 2) 28 tablets - 14 tablets/PTP [28 tablets (14 tablets/PTP x 2)] 30 tablets - 10 tablets/PTP [30 tablets (10 tablets/PTP x 3)]
Approval status
Expired

MFDS item code 202005878 · Approved 2020.08.18

This product's status changed to Expired on 2025.08.18. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
Administer 100mg once daily as monotherapy or combination therapy; the maximum daily dose is 100mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). Administer this medicine regardless of the timing of dialysis.

Ingredients

Manufacturer
Celltrion Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

  • Difficulty in controlling blood sugar levels in patients with type 2 diabetes
View approved original text

This medication is used in conjunction with diet and exercise to help control blood sugar levels in patients with type 2 diabetes. It can be used alone or in combination with other diabetes medications such as metformin in cases where blood sugar control is difficult. Additionally, it helps improve blood sugar control when used with treatments such as sulfonylureas, thiazolidinediones, and insulin. It supports effective blood sugar management in conjunction with various treatment methods.

How to take

Adult dose

Administer 100mg once daily as monotherapy or combination therapy; the maximum daily dose is 100mg. This medicine may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia (see Precautions for Use, 5. General Precautions). Patients with renal impairment Because dose adjustment according to renal function is required, assessment of renal function is recommended before starting this medicine and periodically during treatment. 1. No dose adjustment is required in patients with mild renal impairment (estimated glomerular filtration rate [eGFR] ≥ 60 mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 45 mL/min/1.73 m2 and < 60 mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (estimated glomerular filtration rate [eGFR] ≥ 30 mL/min/1.73 m2 and < 45 mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (estimated glomerular filtration rate [eGFR] ≥ 15 mL/min/1.73 m2 and < 30 mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (estimated glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). Administer this medicine regardless of the timing of dialysis.

Precautions

This medication may cause allergic reactions; therefore, if symptoms such as skin rash or difficulty breathing occur, discontinue use immediately and consult a doctor. While taking this medication, severe inflammation of the pancreas known as acute pancreatitis may occur; if symptoms such as abdominal pain or vomiting arise, notify healthcare professionals promptly. Patients with type 1 diabetes or diabetic ketoacidotic conditions should not take this medication, and those with allergies to this medication or its components should also avoid use. Patients with reduced kidney function need to adjust the dosage of this medication, so consult with a doctor to determine the appropriate dosage based on kidney status. This medication may induce hypoglycemia, especially when taken with insulin or sulfonylureas, so regularly monitor blood sugar levels and be aware of symptoms of hypoglycemia. Severe joint pain may occur, so if severe pain persists, inform a doctor to receive appropriate measures. If there are blisters or inflammation on the skin, discontinue use of this medication immediately and consult a dermatologist. Pregnant or breastfeeding women should preferably avoid using this medication, and safety has not been established for children and adolescents under 18 years of age. Elderly patients may experience reduced kidney function, necessitating dosage adjustments and regular kidney function monitoring. In case of overdose, remove the medication from the gastrointestinal tract and closely observe the condition including the electrocardiogram; consider blood dialysis if necessary. This medication may interact with some drugs, so if other medications are being taken, it is essential to inform a doctor or pharmacist.

Side effects

  • Severe hypersensitivity reaction
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative dermatitis
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
Show 34 more
  • diarrhea
  • abdominal pain
  • nausea
  • constipation
  • vomiting
  • severe and disabling arthralgia
  • blistering dermatitis
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • acute renal failure
  • elevated liver enzymes
  • rash
  • urticaria
  • cutaneous vasculitis
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased ALT
  • increased AST
  • elevated serum triglycerides
  • gastritis
  • weight loss
  • hypertension
  • hypernatremia
  • erectile dysfunction

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly sealed container to prevent air exposure and keep it at a temperature between 1 and 30 degrees Celsius. This helps maintain the effectiveness of the medication for a longer period.

Appearance and packaging

Appearance

Light orange, round, double convex, film-coated tablet

Package unit

28 tablets (14 tablets/PTP x 2) 28 tablets - 14 tablets/PTP [28 tablets (14 tablets/PTP x 2)] 30 tablets - 10 tablets/PTP [30 tablets (10 tablets/PTP x 3)]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.